{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:30Z","timestamp":1790422650129,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,18]],"date-time":"2015-01-18T00:00:00Z","timestamp":1421539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,1,18]],"date-time":"2015-01-18T00:00:00Z","timestamp":1421539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves outcomes. We compared the predictive accuracy of two recently published screening algorithms (DETECT 2013 and Australian Scleroderma Interest Group (ASIG) 2012) for SSc-associated PAH (SSc-PAH) with the commonly used European Society of Cardiology\/European Respiratory Society (ESC\/ERS 2009) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 73 consecutive SSc patients with suspected PAH undergoing right heart catheterization (RHC). The three screening models were applied to each patient. For each model, contingency table analysis was used to determine sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values for PAH. These properties were also evaluated in an \u2018alternate scenario analysis\u2019 in which the prevalence of PAH was set at 10%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RHC revealed PAH in 27 (36.9%) patients. DETECT and ASIG algorithms performed equally in predicting PAH with sensitivity and NPV of 100%. The ESC\/ERS guidelines had sensitivity of 96.3% and NPV of only 91%, missing one case of PAH; these guidelines could not be applied to three patients who had absent tricuspid regurgitant (TR) jet. The ASIG algorithm had the highest specificity (54.5%). With PAH prevalence set at 10%, the NPV of the models was unchanged, but the PPV dropped to less than 20%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cohort, the DETECT and ASIG algorithms out-perform the ESC\/ERS guidelines, detecting all patients with PAH. The ESC\/ERS guidelines have limitations in the absence of a TR jet. Ultimately, the choice of SSc-PAH screening algorithm will also depend on cost and ease of application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-015-0517-5","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T06:37:39Z","timestamp":1421303859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanjie","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Morrisroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Rabusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Zochling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Rischmueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,18]]},"reference":[{"key":"517_CR1","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.38029","volume":"65","author":"G Lef\u00e8vre","year":"2013","unstructured":"Lef\u00e8vre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013;65:2412\u201323.","journal-title":"Arthritis Rheum"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.30541","volume":"63","author":"M Humbert","year":"2011","unstructured":"Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63:3522\u201330.","journal-title":"Arthritis Rheum"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","volume":"371","author":"N Gali\u00e8","year":"2008","unstructured":"Gali\u00e8 N, Rubin LJ, Hoeper MM, Jansa P, Al-Hiti H, Meyer G, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008;371:2093\u2013100.","journal-title":"Lancet"},{"key":"517_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/acr.22121","volume":"66","author":"L Chung","year":"2014","unstructured":"Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, et al. Survival and predictors of mortality in systemic sclerosis associated pulmonary arterial hypertension: Outcomes from the PHAROS registry. Arthritis Care Res (Hoboken). 2014;66:489\u201395.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"517_CR5","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493\u2013537.","journal-title":"Eur Heart J"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3899\/jrheum.090661","volume":"37","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, et al. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS Group. J Rheumatol. 2009;37:105\u201315.","journal-title":"J Rheumatol"},{"key":"517_CR7","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3899\/jrheum.110512","volume":"38","author":"SC Mathai","year":"2011","unstructured":"Mathai SC, Sibley CT, Forfia PR, Mudd JO, Fisher MR, Tedford RJ, et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011;38:2410\u20138.","journal-title":"J Rheumatol"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1002\/art.30432","volume":"63","author":"C Meune","year":"2011","unstructured":"Meune C, Avouac J, Airo\u2019 P, Beretta L, Dieud\u00e9 P, Wahbi K, et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum. 2011;63:2790\u20136.","journal-title":"Arthritis Rheum"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1002\/art.30535","volume":"63","author":"BE Schreiber","year":"2011","unstructured":"Schreiber BE, Valerio CJ, Keir GJ, Handler C, Wells AU, Denton CP, et al. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Arthritis Rheum. 2011;63:3531\u20139.","journal-title":"Arthritis Rheum"},{"key":"517_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","volume":"43","author":"D Mukerjee","year":"2004","unstructured":"Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford). 2004;43:461\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar3876","volume":"14","author":"V Thakkar","year":"2012","unstructured":"Thakkar V, Stevens MW, Prior D, Moore OA, Byron J, Liew D, et al. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case\u2013control study. Arthritis Res Ther. 2012;14:R143\u201353.","journal-title":"Arthritis Res Ther"},{"key":"517_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/art.23187","volume":"58","author":"Y Allanore","year":"2008","unstructured":"Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al. High N-terminal pro\u2013brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum. 2008;58:284\u201391.","journal-title":"Arthritis Rheum"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar4383","volume":"15","author":"V Thakkar","year":"2013","unstructured":"Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, et al. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther. 2013;15:R193.","journal-title":"Arthritis Res Ther"},{"key":"517_CR14","first-page":"1","volume":"00","author":"JG Coghlan","year":"2013","unstructured":"Coghlan JG, Denton PC, Gr\u00fcnig E, Bonderman D, Distler O, Khanna D, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2013;00:1\u201310.","journal-title":"Ann Rheum Dis"},{"key":"517_CR15","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980; 23:581\u2013590.","DOI":"10.1002\/art.1780230510"},{"key":"517_CR16","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573\u20136.","journal-title":"J Rheumatol"},{"key":"517_CR17","unstructured":"PAH risk calculator [http:\/\/detect-pah.com]"},{"key":"517_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720\u201335.","journal-title":"Eur Respir J"},{"key":"517_CR19","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3899\/jrheum.100245","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Airo P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and meta-analysis of 5 studies. J Rheumatol. 2010;37:2290\u20138.","journal-title":"J Rheumatol"},{"key":"517_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3899\/jrheum.090697","volume":"37","author":"AA Shah","year":"2010","unstructured":"Shah AA, Wigley FM, Hummers LK. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol. 2010;37:98\u2013104.","journal-title":"J Rheumatol"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.10-2473","volume":"140","author":"D Launay","year":"2011","unstructured":"Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, et al. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Chest. 2011;140:1016\u201324.","journal-title":"Chest"},{"key":"517_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/03009740801978871","volume":"37","author":"C Kampolis","year":"2008","unstructured":"Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol. 2008;37:278\u201383.","journal-title":"Scand J Rheumatol"},{"key":"517_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00296-010-1557-4","volume":"31","author":"T Dimitroulas","year":"2011","unstructured":"Dimitroulas T, Giannakoulas G, Dimitroula H, Sfetsios T, Parcharidou D, Karvounis H, et al. Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. Rheumatol Int. 2011;31:263\u20137.","journal-title":"Rheumatol Int"},{"key":"517_CR24","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/00029330-200812020-00006","volume":"121","author":"X Jiang","year":"2008","unstructured":"Jiang X, Han ZY, Wang Y, Xu XQ, Ma CR, Wu Y, et al. Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension. Chin Med J (Engl). 2008;121:2497\u2013503.","journal-title":"Chin Med J (Engl)"},{"key":"517_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1183\/09031936.00091212","volume":"42","author":"BD Fox","year":"2013","unstructured":"Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J. 2013;42:1083\u201391.","journal-title":"Eur Respir J"},{"key":"517_CR26","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"38","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E, Steen VD, PHAROS Investigators. Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol. 2011;38:2172\u20139.","journal-title":"J Rheumatol"},{"key":"517_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","volume":"179","author":"R Condliffe","year":"2008","unstructured":"Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2008;179:151\u20137.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0517-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0517-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0517-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0517-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:29:27Z","timestamp":1728908967000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0517-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0517-5","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,18]]},"assertion":[{"value":"27 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}